WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (Nasdaq:BMET) announced today that Biomet Orthopedics formed a strategic research alliance with Massachusetts General Hospital to collaborate on clinical outcome research for Biomet’s recently introduced Regenerex™ and E-Poly™ technologies. Massachusetts General Hospital has agreed to manage the global multi-center prospective clinical studies sponsored by Biomet to provide documented outcomes for these exciting new products.
